Impact of Hypoglycemia on Brain Metabolism During Diabetes

Ashish K. Rehni, Kunjan R Dave

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Diabetes is a metabolic disease afflicting millions of people worldwide. A substantial fraction of world’s total healthcare expenditure is spent on treating diabetes. Hypoglycemia is a serious consequence of anti-diabetic drug therapy, because it induces metabolic alterations in the brain. Metabolic alterations are one of the central mechanisms mediating hypoglycemia-related functional changes in the brain. Acute, chronic, and/or recurrent hypoglycemia modulate multiple metabolic pathways, and exposure to hypoglycemia increases consumption of alternate respiratory substrates such as ketone bodies, glycogen, and monocarboxylates in the brain. The aim of this review is to discuss hypoglycemia-induced metabolic alterations in the brain in glucose counterregulation, uptake, utilization and metabolism, cellular respiration, amino acid and lipid metabolism, and the significance of other sources of energy. The present review summarizes information on hypoglycemia-induced metabolic changes in the brain of diabetic and non-diabetic subjects and the manner in which they may affect brain function.

Original languageEnglish (US)
Pages (from-to)1-14
Number of pages14
JournalMolecular Neurobiology
DOIs
StateAccepted/In press - Apr 10 2018

Fingerprint

Hypoglycemia
Brain
Cell Respiration
Ketone Bodies
Metabolic Diseases
Health Expenditures
Metabolic Networks and Pathways
Glycogen
Lipid Metabolism
Delivery of Health Care
Amino Acids
Glucose
Drug Therapy

Keywords

  • Amino acid metabolism
  • Glucose
  • Glucose transporters
  • Lipid metabolism
  • Metabolomics
  • Neuron

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Impact of Hypoglycemia on Brain Metabolism During Diabetes. / Rehni, Ashish K.; Dave, Kunjan R.

In: Molecular Neurobiology, 10.04.2018, p. 1-14.

Research output: Contribution to journalArticle

@article{04eebb46967a4d0eb4a865d9024c2fac,
title = "Impact of Hypoglycemia on Brain Metabolism During Diabetes",
abstract = "Diabetes is a metabolic disease afflicting millions of people worldwide. A substantial fraction of world’s total healthcare expenditure is spent on treating diabetes. Hypoglycemia is a serious consequence of anti-diabetic drug therapy, because it induces metabolic alterations in the brain. Metabolic alterations are one of the central mechanisms mediating hypoglycemia-related functional changes in the brain. Acute, chronic, and/or recurrent hypoglycemia modulate multiple metabolic pathways, and exposure to hypoglycemia increases consumption of alternate respiratory substrates such as ketone bodies, glycogen, and monocarboxylates in the brain. The aim of this review is to discuss hypoglycemia-induced metabolic alterations in the brain in glucose counterregulation, uptake, utilization and metabolism, cellular respiration, amino acid and lipid metabolism, and the significance of other sources of energy. The present review summarizes information on hypoglycemia-induced metabolic changes in the brain of diabetic and non-diabetic subjects and the manner in which they may affect brain function.",
keywords = "Amino acid metabolism, Glucose, Glucose transporters, Lipid metabolism, Metabolomics, Neuron",
author = "Rehni, {Ashish K.} and Dave, {Kunjan R}",
year = "2018",
month = "4",
day = "10",
doi = "10.1007/s12035-018-1044-6",
language = "English (US)",
pages = "1--14",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",

}

TY - JOUR

T1 - Impact of Hypoglycemia on Brain Metabolism During Diabetes

AU - Rehni, Ashish K.

AU - Dave, Kunjan R

PY - 2018/4/10

Y1 - 2018/4/10

N2 - Diabetes is a metabolic disease afflicting millions of people worldwide. A substantial fraction of world’s total healthcare expenditure is spent on treating diabetes. Hypoglycemia is a serious consequence of anti-diabetic drug therapy, because it induces metabolic alterations in the brain. Metabolic alterations are one of the central mechanisms mediating hypoglycemia-related functional changes in the brain. Acute, chronic, and/or recurrent hypoglycemia modulate multiple metabolic pathways, and exposure to hypoglycemia increases consumption of alternate respiratory substrates such as ketone bodies, glycogen, and monocarboxylates in the brain. The aim of this review is to discuss hypoglycemia-induced metabolic alterations in the brain in glucose counterregulation, uptake, utilization and metabolism, cellular respiration, amino acid and lipid metabolism, and the significance of other sources of energy. The present review summarizes information on hypoglycemia-induced metabolic changes in the brain of diabetic and non-diabetic subjects and the manner in which they may affect brain function.

AB - Diabetes is a metabolic disease afflicting millions of people worldwide. A substantial fraction of world’s total healthcare expenditure is spent on treating diabetes. Hypoglycemia is a serious consequence of anti-diabetic drug therapy, because it induces metabolic alterations in the brain. Metabolic alterations are one of the central mechanisms mediating hypoglycemia-related functional changes in the brain. Acute, chronic, and/or recurrent hypoglycemia modulate multiple metabolic pathways, and exposure to hypoglycemia increases consumption of alternate respiratory substrates such as ketone bodies, glycogen, and monocarboxylates in the brain. The aim of this review is to discuss hypoglycemia-induced metabolic alterations in the brain in glucose counterregulation, uptake, utilization and metabolism, cellular respiration, amino acid and lipid metabolism, and the significance of other sources of energy. The present review summarizes information on hypoglycemia-induced metabolic changes in the brain of diabetic and non-diabetic subjects and the manner in which they may affect brain function.

KW - Amino acid metabolism

KW - Glucose

KW - Glucose transporters

KW - Lipid metabolism

KW - Metabolomics

KW - Neuron

UR - http://www.scopus.com/inward/record.url?scp=85045139439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045139439&partnerID=8YFLogxK

U2 - 10.1007/s12035-018-1044-6

DO - 10.1007/s12035-018-1044-6

M3 - Article

C2 - 29637442

AN - SCOPUS:85045139439

SP - 1

EP - 14

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

ER -